Skip to content

Clinical trials

Phase 3 Macular Degeneration trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20151
20202
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics1
AbbVie1
Allergan1
Alvotech Swiss AG1
Amgen1
Bayer1
Pfizer1
Sam Chun Dang Pharm. Co. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration8
Eye Diseases2
Retinal Degeneration2
Retinal Diseases2
Wet Macular Degeneration2
Blindness1
Choroidal Neovascularization1
Vision Disorders1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.